Display Settings:

Format

Send to:

Choose Destination
    Int J Oncol. 2002 Sep;21(3):461-8.

    Gene therapy for ovarian cancer (review).

    Source

    Department of Gynecologic Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 440, Houston, TX 77030, USA. jwolf@mdanderson.org

    Abstract

    The field of gene therapy presents exciting new opportunities for advances in the management of ovarian cancer. Clinical trials of gene therapy for ovarian cancer have explored the feasibility of delivering a variety of agents as well as highlighted problems with the delivery of therapeutic constructs. Major challenges include enhancing gene transfection with improved vectors, minimizing immunogenicity of viral vectors via novel molecular alterations, effecting tumor-selective gene delivery by targeting genetic alterations present only in tumor cells and utilizing tissue-specific promoters for selective transcription of gene products. Gene therapy research presents unique opportunities for extending the spectrum of ovarian cancer treatment possibilities, either alone or in combination with conventional chemotherapy regimens.

    PMID:
    12168087
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk